425 related articles for article (PubMed ID: 36945005)
21. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy.
Yang S; Gao H
Pharmacol Res; 2017 Dec; 126():97-108. PubMed ID: 28501517
[TBL] [Abstract][Full Text] [Related]
22. Advances of bacteria-based delivery systems for modulating tumor microenvironment.
Li S; Yue H; Wang S; Li X; Wang X; Guo P; Ma G; Wei W
Adv Drug Deliv Rev; 2022 Sep; 188():114444. PubMed ID: 35817215
[TBL] [Abstract][Full Text] [Related]
23. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
[TBL] [Abstract][Full Text] [Related]
24. Targeted drug delivery systems for matrix metalloproteinase-responsive anoparticles in tumor cells: A review.
Guo F; Du Y; Wang Y; Wang M; Wang L; Yu N; Luo S; Wu F; Yang G
Int J Biol Macromol; 2024 Feb; 257(Pt 1):128658. PubMed ID: 38065446
[TBL] [Abstract][Full Text] [Related]
25. Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.
Sun Y; Li Y; Shi S; Dong C
Molecules; 2021 May; 26(9):. PubMed ID: 34062992
[TBL] [Abstract][Full Text] [Related]
26. Tumor Microenvironment Sensitive Nanocarriers for Bioimaging and Therapeutics.
Park H; Saravanakumar G; Kim J; Lim J; Kim WJ
Adv Healthc Mater; 2021 Mar; 10(5):e2000834. PubMed ID: 33073497
[TBL] [Abstract][Full Text] [Related]
27. Anticancer nanomedicines harnessing tumor microenvironmental components.
Li Y; Chen Z; Gu L; Duan Z; Pan D; Xu Z; Gong Q; Li Y; Zhu H; Luo K
Expert Opin Drug Deliv; 2022 Apr; 19(4):337-354. PubMed ID: 35244503
[TBL] [Abstract][Full Text] [Related]
28. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.
Gu X; Gao Y; Wang P; Wang L; Peng H; He Y; Liu Y; Feng N
J Control Release; 2021 May; 333():374-390. PubMed ID: 33798666
[TBL] [Abstract][Full Text] [Related]
29. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
30. Novel 'Stereoscopic Response' Strategy Can Be Used in Combination Therapy.
Gu Z; Shaikh AS; Lin G
Crit Rev Ther Drug Carrier Syst; 2018; 35(4):369-390. PubMed ID: 29972682
[TBL] [Abstract][Full Text] [Related]
31. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
32. Bacteria-based nanodrug for anticancer therapy.
Xie YJ; Huang M; Li D; Hou JC; Liang HH; Nasim AA; Huang JM; Xie C; Leung EL; Fan XX
Pharmacol Res; 2022 Aug; 182():106282. PubMed ID: 35662630
[TBL] [Abstract][Full Text] [Related]
33. Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment.
Fan X; Wang K; Lu Q; Lu Y; Liu F; Li L; Li S; Ye H; Zhao J; Cao L; Zhang H; He Z; Sun J
Acta Biomater; 2022 Dec; 154():412-423. PubMed ID: 36280028
[TBL] [Abstract][Full Text] [Related]
34. Rational assembly of RGD/MoS
Mo C; Wang Z; Yang J; Ouyang Y; Mo Q; Li S; He P; Chen L; Li X
J Photochem Photobiol B; 2022 Aug; 233():112487. PubMed ID: 35679748
[TBL] [Abstract][Full Text] [Related]
35. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
36. Nanotherapy Targeting the Tumor Microenvironment.
Gong BS; Wang R; Xu HX; Miao MY; Yao ZZ
Curr Cancer Drug Targets; 2019; 19(7):525-533. PubMed ID: 30569855
[TBL] [Abstract][Full Text] [Related]
37. Improving cancer therapies by targeting the physical and chemical hallmarks of the tumor microenvironment.
Ivey JW; Bonakdar M; Kanitkar A; Davalos RV; Verbridge SS
Cancer Lett; 2016 Sep; 380(1):330-9. PubMed ID: 26724680
[TBL] [Abstract][Full Text] [Related]
38. Leveraging Nanodrug Delivery System for Simultaneously Targeting Tumor Cells and M2 Tumor-Associated Macrophages for Efficient Colon Cancer Therapy.
Zeng J; Sun Y; Sun S; Jiang M; Zhang D; Li W; Liu Z; Shang H; Guan X; Zhang W
ACS Appl Mater Interfaces; 2022 Nov; 14(45):50475-50484. PubMed ID: 36327132
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
Jia M; Zhang D; Zhang C; Li C
J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
[TBL] [Abstract][Full Text] [Related]
40. Tumor Microenvironment-Enabled Nanotherapy.
Wang L; Huo M; Chen Y; Shi J
Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
